Address

Merlin Nexus
230 Park Avenue
Suite 928
New York, NY 10169
United States

Open map


Recent investment activity

KANDO id: 3162

Corporate information

Registration country

Funding rounds

Actual initial investment stage
N/A (1)

Investment activity status
Active investor

Selected investments

Displaying 1 - 11 of 11
Profile Country Date Funding
Auxilium Pharmaceuticals Inc N/A
Calypso Medical Technologies Inc A medical device company developing innovative tools and therapies for the oncology marketa advancing cancer radiation treatment. N/A
ILEX Oncology Inc N/A
Nabi Biopharmaceuticals N/A
Pharmion Corp Initially, Pharmion concentrated its efforts on licensing products in the areas of hematology, oncology and supportive care. N/A
Rigel Pharmaceuticals Inc N/A
Sunesis Pharmaceuticals Inc Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and he N/A
ARYx Therapeutics Inc N/A
Avalon Pharmaceuticals Inc Biopharmaceutical company focused on the discovery and development of small molecule therapeutics for the treatment of cancer. N/A
AVEO Pharmaceuticals Inc Biopharmaceutical company discovering, developing and commercializing cancer therapeutics. N/A Initial investment
Cougar Biotechnology Inc N/A

Past employees

Selected Products / Customers

Financials